Abbott Sells IVD, Point-Of-Care Diagnostics To GE For $8.13 Bil.
This article was originally published in The Gray Sheet
Executive Summary
With GE's $8.13 billion cash purchase of Abbott Laboratories' core in vitro diagnostics unit Jan. 18, the corporate giant is betting it can accelerate growth in a business still recovering from protracted regulatory challenges in the U.S